LB Pharmaceuticals Inc (LBRX)
NASDAQ: LBRX · Real-Time Price · USD
19.97
-1.41 (-6.59%)
At close: Jan 16, 2026, 4:00 PM EST
20.36
+0.39 (1.95%)
After-hours: Jan 16, 2026, 6:44 PM EST
LB Pharmaceuticals Market Cap
LB Pharmaceuticals has a market cap or net worth of $505.22 million as of January 16, 2026.
Market Cap
505.22M
Enterprise Value
194.41M
1-Year Change
n/a
Ranking
Category
Stock Price
$19.97
Market Cap Chart
Since the IPO on September 11, 2025, LB Pharmaceuticals's market cap has increased from $301.50M to $505.22M, an increase of 67.57%. That is a compound annual growth rate of 340.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 505.22M | -10.29% |
| Dec 31, 2025 | 563.16M | 86.78% |
| Sep 11, 2025 | 301.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |